The Brain Plaques and Tangles That Cause Alzheimer’s Disease
The disease seems to develop as beta amyloid plaques and neurofibrillary tau tangles gather inside the brain to clog synapses and nerve cells—but what is its root cause?
There is certainly some controversy over what causes Alzheimer’s disease. While two proteins—beta amyloid and tau—are prime suspects in its progression, uncertainty remains over what initially triggers this debilitating malady. Knowing this origin of AD, be it amyloid or tau or some other source, is a key step toward developing possible treatments to stall or stop the disease.
Alzheimer’s disease manifests as clumps of protein in the brain. Clumps that develop between nerve cells are called beta amyloid plaques (Aβ), while those that form from inside nerve cells are called neurofibrillary tangles, and are made of tau protein.
In the progression of the disease, beta amyloid plaques precede tau tangles, and both are accompanied by inflammation in the brain and eventual neural loss.
Progression of Alzheimer's Disease
Much of what has been learned about beta amyloid and tau has come from experiments done on mice, says Dr. Samuel Gandy, a researcher at Mount Sinai Medical Center. Mice normally do not get Alzheimer’s disease, because their amyloid plaques do not clump. Yet if a set of mutated genes are given to them, it causes build-up of amyloid and tau and the rodent brains become plaque-and-tangle-ridden in patterns similar to those that characterize Alzheimer’s disease. If the mice are then given a substance that lowers the levels of tau alone, cognitive function returns, says Dr. Gandy. "It's possible to sort of render the amyloid inert if you can turn down the tau, at least in the mouse model," says Gandy.
Research has not yet made the jump from mouse to human, and amyloid and other components should not be dismissed in favor of solely tau-based research says Dr. Ottavio Arancio of Columbia University. "It's perfectly possible that one of these abnormalities, let’s say amyloid, may trigger the rest," he says. Further research into each of the many components at work in Alzheimer's disease is warranted, he adds, as any one could lead to a new understanding of how this disease works.
The views expressed here are solely those of the participants, and do not represent the views of Big Think or its sponsors.
- The meaning of the word 'confidence' seems obvious. But it's not the same as self-esteem.
- Confidence isn't just a feeling on your inside. It comes from taking action in the world.
- Join Big Think Edge today and learn how to achieve more confidence when and where it really matters.
- There are 2 different approaches to governing free speech on college campuses.
- One is a morality/order approach. The other is a bottom-up approach.
- Emily Chamlee-Wright says there are many benefits to having no one central authority on what is appropriate speech.
The controversial herbicide is everywhere, apparently.
- U.S. PIRG tested 20 beers and wines, including organics, and found Roundup's active ingredient in almost all of them.
- A jury on August 2018 awarded a non-Hodgkin's lymphoma victim $289 million in Roundup damages.
- Bayer/Monsanto says Roundup is totally safe. Others disagree.
- Economist Sylvia Ann Hewlett breaks down what qualities will inspire others to believe in you.
- Here's how 300 leaders and 4,000 mid-level managers described someone with executive presence.
- Get more deep insights like these to power your career forward. Join Big Think Edge.
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.